Binx Health Molecular Analyzer Binx io® CLIA Waived Sample Dependent - Each - 3.001.001-EA
Binx Health Molecular Analyzer Binx io® CLIA Waived Sample Dependent - Each - 3.001.001-EA
Regular price
$21,983.99
Sale price
$21,983.99
Regular price
Unit price
per
Shipping calculated at checkout.
50 In stock
Estimated deliver:
Flat-Rate Shipping from $8.25
Binx Health Molecular Analyzer Binx io® CLIA Waived Sample Dependent - Each - 3.001.001-EA
| Item Id | 1184010 |
| MF Id# | 3.001.001 |
| Brand | binx io® |
| Manufacturer | Binx Health |
| Country of Origin | Unknown |
| Analyzer Type | Benchtop |
| Application | Molecular Analyzer |
| CLIA Classification | CLIA Waived for Female Vaginal Swabs / Male Urine |
| CLIA Classified | CLIA Waived Sample Dependent |
| Purchase Program Type | Standard Purchase Agreement |
| Sample Type | Vaginal Swab / First Catch Urine Sample |
| Test Name | Chlamydia Trachomatis / Neisseria Gonorrhoeae (CT / NG) |
| Time to Results | 30 Minute Time to Results |
| UNSPSC Code | 41115843 |
Features
- Binx io is the first ever, FDA-cleared, molecular point-of-care platform that enables clinicians to test and treat women and men for the most common STIs, chlamydia and gonorrhea, in a single office visit
- Binx io is a small, desktop instrument that processes a single-use, assay-specific cartridge with no sample preparation necessary
- The binx io has been cleared by the FDA for use in point-of-care and clinical laboratory settings for the rapid and accurate detection of chlamydia and gonorrhea in vaginal swab and first catch urine samples collected by either a clinician or patient
- 3.30.21 CLIA waived for binx health io Instrument (use with female vaginal swabs and male urine) for both Chlamydia and Neisseria gonorrhoeae